BioSpace News Archive

Sensorion, a pioneering clinical-stage biotech company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, announces the appointment of gene therapy expert Géraldine Honnet MD, as Chief Medical Officer.

Sofinnova Partners, a leading European life sciences venture capital firm based in Paris, London and Milan, announced it has appointed Bommy Lee as Head of Communications.

International medical imaging IT and cybersecurity company Sectra has received an order for its radiology imaging solution from the British SWASH consortium of NHS Trusts.

Catalent, Inc. announced that its wholly owned subsidiary, Catalent Pharma Solutions, Inc., intends to offer, subject to market and other conditions, €450.0 million in aggregate principal amount of senior unsecured notes due 2028 in a private offering that is exempt from the registration requirements of the Securities Act of 1933, as amended.

NeoTX Therapeutics, a clinical-stage biotechnology company leveraging its proprietary Selective T cell Redirection platform to develop targeted anticancer immunotherapies, has closed a $45 million Series C financing.

Mereo BioPharma Group plc, “Mereo” or the “Company,” announced that it has entered into a Securities Purchase Agreement with a new U.S.-based institutional healthcare investor.

ViAqua’s first product is a functional feed that enhances shrimp health, reducing disease impact and limiting losses in shrimp aquaculture.

NeuroVive enrolls first subject in its European KL1333 phase Ia/b clinical study

Orexo AB, invites investors, analysts and media to attend the company’s Capital Markets Day, taking place in Stockholm, Sweden, on March 17, at Helio GT30, Grev Turegatan 30.

Atlantic Healthcare plc announces the appointment of Andrew Jones as a non-executive director, bringing more than 25 years of international capital market experience in New York, London & Hong Kong to the Board Of Directors.